Investigation of COVID-19 By Theoretical Docking of Medicines With Two Proteins

Inhibition of COVID-19 RNA-Dependent RNA Polymerase by Natural Bioactive Compounds: Molecular Docking Analysis.

Synthesis and in silico studies of novel pyrazole-based anti-MERS-CoV agents

Antiviral Effect of Curcuminoids and Curcumin Derivatives Against Coronavirus (Sars-Cov-2) Predicted Using Molecular Docking Approach

Novel Thiopyrimidine-5-Carbonitrile Derivatives as VEGFR-2 Inhibitors: Synthesis, Anticancer Evaluation and Molecular Docking Studies

Molecular Docking of Pepstatin (A) and Compounds with Structural Similarity to the Molecular Model of Human BACE-1 Enzyme

Molecular Modeling, Breast Cancer, and Hepatitis A, B, C Molecular Docking Investigation of (2E)-1-phenyl-butane-1,2,3-trione 2-[(2-oxo-2H-chromene-6-yl)hydrazone]

Potential chemical compounds can inhibit SARS CoV-2 replication and open the way for the production of anti-SARS CoV-2 therapy.

Molecular Docking and DFT Study of Synthesized Oxazine Derivatives

Density Functional Theory (DFT) Investigation and Molecular Docking Simulation of 1, 2, 4-triazole Derivatives as Potent Inhibitors Against a Receptor (DNA Gyrase)